PEMT: a patent enrichment tool for drug discovery
Bioinformatics · 2023
DOI: 10.1093/bioinformatics/btac716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2023. Verfasst von Yojana Gadiya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg 22525, Germany. Hauptthemen laut MEDLINE: Software, Metadata. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research, European Union’s Horizon 2020 programme.
Abstract (Originalsprache)
Motivation Drug discovery practitioners in industry and academia use semantic tools to extract information from online scientific literature to generate new insights into targets, therapeutics and diseases. However, due to complexities in access and analysis, patent-based literature is often overlooked as a source of information. As drug discovery is a highly competitive field, naturally, tools that tap into patent literature can provide any actor in the field an advantage in terms of better informed decision-making. Hence, we aim to facilitate access to patent literature through the creation of an automatic tool for extracting information from patents described in existing public resources. Results Here, we present PEMT, a novel patent enrichment tool, that takes advantage of public databases like ChEMBL and SureChEMBL to extract relevant patent information linked to chemical structures and/or gene names described through FAIR principles and metadata annotations. PEMT aims at supporting drug discovery and research by establishing a patent landscape around genes of interest. The pharmaceutical focus of the tool is mainly due to the subselection of International Patent Classification codes, but in principle, it can be used for other patent fields, provided that a link between a concept and chemical structure is investigated. Finally, we demonstrate a use-case in rare diseases by generating a gene-patent list based on the epidemiological prevalence of these diseases and exploring their underlying patent landscapes. Availability and implementation PEMT is an open-source Python tool and its source code and PyPi package are available at https://github.com/Fraunhofer-ITMP/PEMT and https://pypi.org/project/PEMT/, respectively. Supplementary information Supplementary data are available at Bioinformatics online.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg 22525, Germany.
- Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Frankfurt 60590, Germany.
- Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin 53754, Germany.
- Bonn-Aachen International Center for Information Technology (B-IT), University of Bonn, Bonn 53113, Germany.
ORCID-Profile: Yojana Gadiya, Martin Hofmann-Apitius
Förderung
- German Federal Ministry of Education and Research
- European Union’s Horizon 2020 programme
Zitieren
APA
Gadiya, Y., Zaliani, A., Gribbon, P., & Hofmann-Apitius, M. (2023). PEMT: a patent enrichment tool for drug discovery. Bioinformatics. https://doi.org/10.1093/bioinformatics/btac716
Vancouver
Gadiya Y, Zaliani A, Gribbon P, Hofmann-Apitius M. PEMT: a patent enrichment tool for drug discovery. Bioinformatics. 2023. doi:10.1093/bioinformatics/btac716
BibTeX
@article{Gadiya2023,
author = {Gadiya, Yojana and Zaliani, Andrea and Gribbon, Philip and Hofmann-Apitius, Martin},
title = {PEMT: a patent enrichment tool for drug discovery},
journal = {Bioinformatics},
year = {2023},
doi = {10.1093/bioinformatics/btac716}
}
EUVIMED